Objective-Endothelial function depends on the equilibrium in the synthesis of vasoactive endothelial factors. It is well known that endothelin and nitric oxide (NO) exhibit reciprocal regulation. We assessed the ability of NO to regulate endothelin-converting enzyme-1 (ECE-1) expression in vascular endothelial cells. Methods and Results-Bovine aortic endothelial cells were incubated with 2 different NO donors as well as with a cyclic-GMP analog, dibutyryl-cGMP (dB-cGMP). ECE-1 protein content and mRNA expression were evaluated by Western blot and Northern blot, respectively, promoter activity by transfection experiments, ECE-1 activity by ELISA, and cGMP production by radioimmunoassay. Both NO donors decreased ECE-1 protein content, mRNA expression, and ECE-1 activity. ODQ, an inhibitor of soluble guanylyl cyclase, blocked those effects. NO donors raised cGMP levels, and dB-cGMP mimicked their effects on ECE-1 expression, which were blocked by KT5823, a nonspecific PKG inhibitor. The changes on ECE-1 expression were due to a destabilization on 3Ј-untranslated region (3Ј-UTR) of this mRNA, because the activity of a luciferase reporter construct containing the 3Ј-UTR of the ECE-1 gene was reduced by dB-cGMP in a PKG-dependent manner. The biological relevance of this regulation was confirmed in bovine aortic endothelial cells coincubated with macrophages in the presence of lipopolysaccharide, in eNOS-deficient mice, and in Wistar rats treated with NO donors. In every case, an inverse relationship was observed between NO and ECE-1 protein content. 
I
t is a well-known fact that endothelium exerts multiple functions to preserve vascular homeostasis. Vasoactive endothelial factors such as nitric oxide (NO) or endothelin-1 (ET-1) are involved in this regulation. An unbalanced production of these bioactive mediators results in endothelial dysfunction, a critical event in the development of renal and cardiovascular damage in some diseases like diabetes, hypertension, or atherosclerosis. [1] [2] [3] [4] ET-1, discovered in 1988, 5 is the most powerful vasoconstrictor peptide known. Its synthesis is the result of 2 main steps. The first one converts the long precursor prepro-ET-1 into the inactive short precursor big ET-1, and the second one converts big ET-1 specifically into ET-1 through the action of the endothelin-converting enzyme-1 (ECE-1). 6 ECE-1 is a zinc type II membrane metallopeptidase protein, 7 an enzyme with 4 different isoforms generated by alternative splicing. 8 NO is a gaseous metabolite with vasorelaxant properties, synthesized by a family of enzymes known as nitric oxide synthases. 9, 10 ET-1 and NO are synthesized by endothelial cells and are able to regulate each other to maintain a balanced vascular tone. Experimental studies have provided evidence that ET-1 may exert a bidirectional effect on NO production either enhancing its synthesis via ETB receptors or blunting it through ETA receptors. 11, 12 Conversely, NO was found to inhibit ET-1 synthesis in different cell types. [13] [14] [15] Moreover, numerous conditions characterized by an impaired availability of NO have been found to be associated with enhanced synthesis of ET-1, 16 and vice versa, 17 thereby suggesting that these 2 factors have a reciprocal regulation.
ECE-1 activity has been considered critical for ET-1 synthesis, and it has been demonstrated that the blockade of this protein exerts beneficial effect in some cardiovascular diseases. 12, 18 For this reason, its regulation has been actively investigated. Reactive oxygen species, 19, 20 oxidized lowdensity lipoproteins, 21 angiotensin II, 22 and big ET-1 itself 23 may be involved in the regulation of its activity or content. However, the possibility that NO could modulate the synthesis or activity of ECE-1, a mechanism that could contribute to the cross-regulation between NO and ET-1, has not been adequately explored. Thus, this study was devoted to assess the effect of NO on ECE-1 levels in bovine aortic endothelial cells (BAEC) , as well as to analyze the mechanisms involved in this regulation.
Methods

Cell Culture
The culture of BAEC, 19 EA.hy926 human endothelial cell line, murine-derived RAW 264.7 macrophage cell line (RAW), 24 and human embryonic kidney 293T, as well as the BAEC and RAW cocultures 22 were performed as described (please see Supplemental data, available online at http://atvb.ahajournals.org).
Animal Studies
Treatment of different animals were done as described (please see Supplemental data). The study design and the experimental protocols were performed in agreement with the Guide for the Care and Use of Laboratory Animals published by the US National Institute of Health (NIH Publication No.85 to 23, revised 1996) and with the European Union regulations.
Analytic Procedures
Immunoblot Analysis
Detection and quantification of ECE-1 protein from BAEC and tissues were done by immunoblotting as described previously, 23 using a monoclonal anti-ECE-1 antibody (mAb AEC32-236 was provided by Dr. Kohei Shimada, Biological Research Laboratories, Sankyo Co, Ltd, Tokyo, Japan).
RNA Isolation and Northern Blot Analysis
Total RNA from BAEC was isolated as described. 21, 25 For Northern analysis, a 2900-bp fragment of bovine ECE-1 19 and an 18S RNA probe were radiolabeled (Ready to Go, GE Healthcare Bio-Sciences, Buckinghamshire, UK).
Measurement of ECE-1 Activity
Membrane proteins from BAEC treated with dB-cGMP were homogenized as described. 23 Then, 30 g of the homogenate were incubated with bovine big ET-1 (100 nmol/L) for 4 hours at 37°C in 50 mmol/L Tris-HCl buffer pH 7.0. 20 ET-1 production from cultured cells or plasma from rats was measured by ELISA.
Measurement of Cyclic GMP
Cyclic GMP was extracted from BAEC following published methods 26 ; cGMP production in each sample was measured by radioimmunoassay and corrected by protein amount (please see Supplemental data).
Nitrite Determination
Nitrite synthesis was evaluated by a fluorimetric assay using 2,3-diaminonaphtalene as described. 27 
Transient Transfection Experiments
Promoter activity of ECE-1 was analyzed by transfection with a human ECE-1 promoter/luciferase plasmid as described. 19, 21 Potential effects at the 3Ј-UTR level were studied using luciferase constructs fused to the 3Ј-UTR of the ECE-1 gene (pSGG-full length 3Ј-UTR-ECE-1 and deletional constructs from this, please see http://atvb.ahajournals.org). 28, 29 Additionally, the role of the 3Ј-UTR region was proven by using ECE-1 transgenes with (pCMV6-UTR-ECE1) or without this region (pCMV6-ECE1) (Please see Supplemental data). PKG involvement was studied using a dominant-negative form and a constitutively active construct of PKG-1␣, 30, 31 which were kindly donated by Dr D. Browning (Medical College of Georgia, Augusta, GA).
Statistical Analysis
Unless otherwise specified, data are expressed as meansϮSEM and as a percentage of the control values. All experiments were performed at least 3 times in duplicate. Comparisons were made by nonparametric statistics, particularly the Wilcoxon (2 groups) or Friedman (more than 2 groups) tests. Animal studies were analyzed by ANOVA, followed by the Scheffe multiple comparison test, after confirming the normality of the data distribution. The level of statistical significance was defined as PϽ0.05.
Results
NO-Dependent Changes in ECE-1 Protein Content and its Dependence On Soluble Guanylyl Cyclase
Confluent BAEC monolayers were incubated with 2 different NO donors, sodium nitroprusside (SNP) and diethylamine/ nitric oxide complex sodium salt (DEA-NO) at different times and dosage, to evaluate their effects on ECE-1 expression. Figure 1 shows how both NO donors were able to decrease ECE-1 protein content in a dose-and timedependent fashion. The reduction was maximal at 24 hours ( Figure 1B and 1D ) and was attained with relatively low concentrations of 0.1 mol/L for SNP ( Figure 1A ) and 100 mol/L for DEA-NO ( Figure 1C ). This effect depended on soluble guanylyl cyclase (sGC) through cyclic GMP generation, as supported by different experimental approaches. First, both NO donors induced cyclic GMP production, which was completely blocked in the presence of ODQ (Figure 2A ). Second, a permeable analog of cyclic GMP, such as dibutyryl-cGMP (dB-cGMP), induced a significant reduction of ECE-1 protein content ( Figure 2B ) that was dose-( Figure 2C ) and time-dependent ( Figure 2D ), mimicking the effects observed with SNP and DEA-NO. The effect of dB-cGMP was maximal at 8 hours with a dose of 10 mol/L. Finally, the NO-dependent ECE-1 downregulation was completely blocked by ODQ, a specific inhibitor of sGC ( Figure 2B ). These changes in protein content were corresponded by changes in enzyme activity. When BAEC were incubated with 10 mol/L dB-cGMP for 6 hours, the total ECE-1 activity in cell extracts decreased about 50% (Control values: 11.25Ϯ2.68 fmol/mL ET-1; dB-cGMP values: 4.75*Ϯ1.32 fmol/mL ET-1; *PϽ0.05). Additional data support these findings. The blockade of NO synthesis with L-NAME increased ECE-1 content, whereas the treatment with DEA-NO plus dB-cGMP did not enhance ECE-1 downregulation, when compared with the effect promoted by each one alone, both in bovine and in human endothelial cells (please see Supplemental Figure IA ). Finally, the inhibitory effect of NO donors and dB-cGMP was also evident in cells in which ECE-1 protein content was upregulated by high glucose concentration (please see Supplemental Figure IB ).
Role of PKG in the ECE-1 Downregulation Elicited by NO Donor and dB-cGMP
The role of PKG was studied by pretreating BAEC with a nonspecific PKG inhibitor, KT5823, and measuring ECE-1 protein content by Western blot. KT5823 completely blocked the downregulation of ECE-1 induced by DEA-NO and dB-cGMP ( Figure 3A ), at concentrations that inhibited phosphorylation of the vasodilatorstimulated phosphoprotein (P-VASP-Ser239) ( Figure 3B ). Besides, to confirm the involvement of PKG in the reduction of ECE-1 protein levels, BAEC were transfected with a dominant-negative PKG isoform, active PKG, or an empty vector; and ECE-1 protein content was evaluated by Western blot after 6 hours of treatment with dB-cGMP ( Figure 3C ). ECE-1 protein content was reduced by treatment with dB-cGMP in BAEC transfected with empty vector, an effect that was not observed in cells transfected with a dominant-negative of PKG. In contrast, the constitutively active PKG construct itself was able to reduce ECE-1 protein content as dB-cGMP.
Mechanism Involved in the Modulation of ECE-1 by dB-cGMP
The ability of dB-cGMP to modulate ECE-1 mRNA expression was tested. A significant decrease of ECE-1 mRNA was found in cells incubated with several doses ( Figure 4A ) and for different times ( Figure 4B ) of dB-cGMP. To assess if this mRNA ECE-1 downregulation was due to transcriptional changes, the ECE-1 promoter activity was measured by transitory transfection assays using an ECE-1 promoter fragment (Ϫ682/ϩ1 bp) linked to a luciferase expression reporter. The 5Ј-flanking region of the ECE-1a gene contains a CAAT box and potential binding sites for glucocorticoid receptors, NF-kappaB, PU-1, AP1, AP2, and c-ets1 transcription factors. 19, 21, 32 The addition of dB-cGMP to BAEC produced no significant changes in ECE-1 promoter activity ( Figure 4C ). Phorbol myristate acetate (3ϫ10 Ϫ7 mol/L, 6 hours) was used as a positive control in these assays 32 (Stimulation: 283Ϯ18% versus control cells), and SP-600125 (25 mol/L, 6 hours), an AP-1 inhibitor that inhibits JNK, induced a moderate reduction around 25% (76Ϯ9% versus control cells). As no obvious effect was found at the level of ECE-1 gene transcription, ECE-1 mRNA stability in cells treated with dB-cGMP was checked using the transcriptional inhibitor 5, 6-dichloro-1-␤-D-ribofuranosyl-benzimidazole (DRB). Figure 4D shows that the treatment of control cells with DRB produced no significant reduction in the levels of ECE-1 mRNA, a result suggesting that this mRNA is quite stable throughout the experimental time course. In contrast, ECE-1 mRNA content was diminished in cells treated with DRB plus dB-cGMP and DRB plus DEA-NO, an observation that suggests a reduction in mRNA stability.
Many of the regulatory mechanisms at the posttranscriptional level take place within genetic elements present in the 3Ј-untranslated region (3Ј-UTR) of the genes. 33 In order to assess if the 3Ј-UTR of the ECE-1 mRNA was involved in the cGMP-mediated ECE-1 mRNA destabilization, we generated a luciferase reporter under the control of a ribosomal protein L10 constitutive promoter, with the 3Ј-UTR of the human ECE-1 gene (full length 2707 bp fragment) cloned downstream of the reporter gene (pSGG-full length 3Ј-UTR-ECE). Transient transfection experiments in BAEC incubated with dBcGMP for different time periods are shown in Figure 5A ; dB-cGMP reduced the luciferase activity in the pSGG-full length 3Ј-UTR-ECE (UTR) construct, but not in the control plasmid pSGG-empty (⌬UTR). In order to study whether the cGMP-mediated destabilizing effect can be assigned to specific regions of the 3Ј-UTR, we divided the full-length sequence into 3 smaller fragments (1 to 639, 640 to 1425 and 1426 to 2707). Figure 5B shows that the plasmid containing the subfragment 640 to 1425 recapitulated the effect of the full length construct, a result indicating that regulatory elements involved in the action of cGMP are contained within this sequence. To confirm this finding, the 3Ј-UTR of the ECE-1 gene was cloned downstream of the ECE-1 gene (pCMV6-UTR-ECE1) and the construct was expressed in a human embry- onic kidney 293T cell line, a cell line that does not constitutively express ECE-1. Control construct, without the 3Ј-UTR region (pCMV6-ECE1), was expressed in parallel. ECE-1 protein content was evaluated by Western blot in cells treated with dB-cGMP. Figure 5C shows that only in the presence of the 3Ј-UTR, dB-cGMP is able to reduce ECE-1 expression.
Importance of PKG in the Post-Transcriptional Changes Induced by dB-cGMP in ECE-1
Overexpression of the catalytic region of PKG-1␣ (constitutively active PKG), which retains kinase activity in the absence of cGMP, reproduced the effects of dB-cGMP on pSGG-full length 3Ј-UTR luciferase ( Figure 5D ). Transfection with the regulatory region of PKG-1␣ (dominantnegative PKG), which acts as a dominant-negative for PKG-1␣ activity, led to the abrogation of the dB-cGMP effect ( Figure 5D ). Transfection efficiency was verified by immunologic detection with anti-Flag antibody (please see Supplemental Figure II ).
Assessment of the Biological Relevance of the NO-Dependent ECE-1 Downregulation In Vitro
To evaluate the biological relevance of the NO/cGMPdependent ECE-1 downregulation, BAEC were incubated with macrophages (RAW 264.7 cells), in the presence of lipopolysaccharide (LPS), a known stimulus of NO production by macrophages. Figure 6A shows that BAEC incubated with LPS-activated macrophages exhibited a reduction in ECE-1 protein levels and ET-1 production. Indeed, when BAEC were treated with LPS alone, a slight up-regulation of ECE-1 protein content and ET-1 production was observed, as previously described. 34 LPS increased significantly the nitric oxide production when BAEC were incubated with RAW with respect to BAEC alone ( Figure 6A ). To confirm that iNOS was responsible for increased NO levels, coculture of BAECϩRAW were incubated in the presence of different doses of an iNOS inhibitor, 1400W, which was able to complete abolish NO synthesis at 1000 nmol/L and also reversed the LPSinduced ECE-1 decrease ( Figure 6A ). On the other hand, the treatment with ODQ, a soluble guanylyl cyclase inhibitor, completely prevented the LPS effect on ECE-1 protein content in the BAECϩRAW coculture, without modifying NO synthesis ( Figure 6A ). For control purposes, nitrite concentrations (mol/L) in supernatants were also measured in RAW alone (0.06Ϯ0.016) or incubated with 0.1 g/mL LPS (45Ϯ4.8), and in BAEC alone (0.32Ϯ0.08), or incubated with 250 mol/L DEA-NO (2.34Ϯ0.07) or 1 mol/L L-NAME (0.11Ϯ0.06).
Assessment of the Biological Relevance of the NO-Dependent ECE-1 Downregulation In Vivo
Lung tissues from 8-week-old eNOS deficient mice expressed higher levels of ECE-1 protein than their wild-type counterparts ( Figure 6B ). When these mice were treated with SNP, 2 g/Kg via IP, for 24 hours, lung ECE-1 protein content decreased, not only in wild-type but also in eNOS deficient mice ( Figure 6B ). Wild-type mice treated with L-NAME, 50 mg/Kg/d dissolved in drink water for 72 hours, also exhibited an increased ECE-1 protein content in lungs ( Figure 6C ). Finally, rats treated with NO donors showed a significant reduction of ECE-1 protein content in aorta and lung tissues (please see Supplemental Figure III ), as well as in circulating ET-1 levels (Control rats: 4.7 fmol/mL ET-1; SNP-treated rats: 3.4 fmol/mL ET-1, nϭ5 in each case, PϽ0.05).
Discussion
Our data suggest a new role for the NO/cGMP/PKG pathway in the vascular endothelium. Nitric oxide, through 2 53*±6.7 95±6.6 98±7.3 101±5.4  1.1±0.2 4.8*±0.3 2.6±0.2 1.8±0.2 1.2±0.1 activation of the soluble guanylyl cyclase, cGMP synthesis, and PKG activation, downregulates ECE-1 expression. According to our results, the mechanism seems to involve a destabilization of ECE-1 mRNA, in which the 3Ј-UTR region plays a key role. ECE-1 is the key enzyme in ET-1 synthesis, and this peptide is involved in the pathogenesis of different cardiovascular diseases. Our results demonstrate that NO donors decrease the ECE-1 protein content in vascular endothelial cells, suggesting that this enzyme could be considered as a target for NO in the local NO-ET-1 cross regulation within the vascular endothelium. One of the few studies that have previously evaluated the ability of NO to regulate ECE-1 expression was that of Kelly et al. 13 This study was devoted to analyze the effect of diethylenetriamine/nitric oxide adduct, a long-acting nitric oxide donor, on ET-1 synthesis in ovine pulmonary arterial endothelial cells. They found that diethylenetriamine/nitric oxide adduct decreased ET-1 secretion and prepro-ET-1 mRNA without changes in ECE-1 expression. It is possible that differences in cell type could account for the divergent findings in our study regarding the effects on ECE-1 expression. Alternatively, the chemical nature of the selected NO donors could contribute to explain the observed differences, as DEA-NO releases NO more rapidly, in contrast to the more sustained and quantitatively lower action of diethylenetriamine/nitric oxide adduct. However, it is important to note that in our study NO action was mediated by its natural effector, cGMP. In this sense, Uchida et al 35 also revealed that the expression of ECE-1 and ECE-2 were downregulated by 8-bromo-cGMP through PKG-mediated signaling in glomerular endothelial cells.
ECE-1 Tubulin
Most of cellular actions of NO are mediated by a classical pathway in which the activation of soluble guanylyl cyclase, the synthesis of cGMP, and the activation of PKG are involved. 13,36 -39 We tested the possibility that this pathway could be responsible for the decrease in ECE-1 protein content observed in cells incubated with NO donors. As expected, NO donors increased cGMP, and this stimulation was blocked by ODQ, a soluble guanylyl cyclase inhibitor. ODQ also inhibited the effect of NO donors on ECE-1 protein content. Moreover, exogenously added cGMP reproduced the effects of NO on ECE-1 by activating PKG, as the blockade of this enzyme abrogated the inhibitory effect of cGMP on ECE-1 protein content. Taken together, these results strongly support that the regulation of ECE-1 by NO is regulated by the canonical NO/sGC/cGMP/PKG pathway.
Our data are consistent with a post-transcriptional mechanism of regulation of ECE-1 mRNA, mediated by PKG 40 and involving a reduction in its stability. We also provide insight about the specific region of the 3Ј-UTR responsible for this effect. Our results indicate that the central portion between positions 640 to 1425 with respect to the stop codon contains the elements required for this downregulation. Previous reports in the bibliography have already shown that the cGMP pathway can modulate message stability of different mRNAs, including the ␣1 and ␤1 subunits of soluble guanylyl cyclase, the inducible NO synthase, COX-1, TNF-␣, and TGF-␤3. 40 Of interest, the contribution of the 3Ј-UTR of ECE-1 to the regulation of ECE-1 protein content has also been reported in a model of hepatic wound healing. 41 These authors demonstrated that the increased ECE-1 content observed in this model was the consequence of increased mRNA stability, and that the 3Ј-UTR was critical in the maintenance of this stability. 41 It has been proposed that these effects may involve the downregulation of the RNA-stabilizing factor HuR, a protein that binds preferably to adenine-and uridine-rich regions.. However, it is not obvious that adenine and uridine-rich elements are present in the subfragment 640 to 1425 of the 3Ј-UTR ECE-1 mRNA. On the other hand, there is accumulating evidence that microRNAs (miRNA) control multiple aspects of cell biology by silencing gene expression. 42 In most cases silencing occurs by inhibition of translation or mRNA degradation through a specific interaction with the 3Ј-UTR of the target mRNA. Different specific miRNAs have been shown to influence endothelial function, including proliferation, migration and morphogenesis. 43 For example, miR-296 has been shown to be a critical component of the angiogenic process. The miRNAs miR-221 and miR-222, on the contrary, have been shown to inhibit endothelial cell migration, proliferation and angiogenesis in vitro by targeting stem cell factor receptor. 44 Computer-assisted analysis of putative miRNA binding sites in the fragment 640 to 1425 of ECE-1 3Ј-UTR (Microinspector algorithm, http:/bioinfo.uni-provdiv.bg/ microinspector/) have revealed the existence of potential binding sites for miRNAs of endothelial interest, miR-296, miR-221, or miR-20a/b. Whether any of these miRNAs are regulated by NO/cGMP and interact with ECE-1 3Ј-UTR are specific objectives of our current investigation.
The addition of NO donors is a pharmacological intervention that attempts to mimic the effect of endogenous NO. To assess the biological relevance of the NO-dependent ECE-1 regulation, we checked ECE-1 protein levels in BAEC cocultured with a macrophage cell line treated with LPS for 24 hours. It is well known that LPS induces NO production in macrophages. 45 BAEC incubated with LPS alone showed increased ET-1 production and ECE-1 expression. In contrast, BAEC cocultured with macrophages plus LPS showed significantly decreased ET-1 production and ECE-1 expression, an effect that was blocked by ODQ and 1400W. The biological relevance of the in vitro studies was confirmed in aorta and lung tissues of SNP-treated rats, which showed reduced ECE-1 content and lower circulating ET-1 levels. Furthermore, lungs extracted not only from eNOS-deficient mice but also from L-NAME-treated wild-type mice presented higher expression of ECE-1 than their wild-type counterparts, supporting the relevance of NO in this effect.
In consequence, the present results clearly demonstrated that NO downregulates ECE-1 in cultured cells and in animals, through a mechanism in which the sGC/cGMP/PGK pathway is involved. The activation of this system induces a destabilization of the ECE-1 mRNA with participation of the 3Ј-UTR of the gene. These findings support the biological relevance of the cross-regulation between NO and the endothelin system and point to ECE-1 as a target for NO.
